Verrica Pharmaceuticals Ownership | Who Owns Verrica Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Verrica Pharmaceuticals Ownership Summary


Verrica Pharmaceuticals is owned by 40.11% institutional investors, 32.18% insiders, and 27.71% retail investors. Perceptive advisors is the largest institutional shareholder, holding 15.27% of VRCA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.79% of its assets in Verrica Pharmaceuticals shares.

VRCA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVerrica Pharmaceuticals40.11%32.18%27.71%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Perceptive advisors7.10M15.27%$51.75M
Vanguard group1.27M2.73%$9.25M
Blackrock1.13M2.43%$8.23M
Fmr1.11M2.39%$8.08M
Geode capital management463.36K1.00%$3.38M
State street451.78K0.97%$3.29M
Propel bio management424.94K0.91%$3.10M
Invesco423.52K0.91%$3.09M
Simplify asset management280.00K0.60%$2.04M
Northern trust190.68K0.41%$1.39M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Propel bio management424.94K2.01%$3.10M
Perceptive advisors7.10M1.23%$51.75M
Bml capital management180.00K0.94%$1.31M
Simplify asset management280.00K0.14%$2.04M
Steel peak wealth management122.84K0.04%$895.48K
Spc financial30.00K0.02%$218.70K
Key financial9.41K0.02%$68.64K
Miracle mile advisors84.00K0.01%$612.36K
Bridgeway capital management82.20K0.01%$599.24K
Kovitz investment group partners100.13K0.01%$729.91K

Top Buyers

HolderShares% AssetsChange
Propel bio management424.94K2.01%424.94K
Invesco423.52K0.00%423.52K
Simplify asset management280.00K0.14%280.00K
Kovitz investment group partners100.13K0.01%50.00K
Renaissance45.52K0.00%45.52K

Top Sellers

HolderShares% AssetsChange
Avoro capital advisors---4.00M
Fmr1.11M0.00%-400.50K
Kornitzer capital management inc /ks---74.25K
Eam investors---70.59K
Morgan stanley84.94K--49.28K

New Positions

HolderShares% AssetsChangeValue
Propel bio management424.94K2.01%424.94K$3.10M
Invesco423.52K0.00%423.52K$3.09M
Simplify asset management280.00K0.14%280.00K$2.04M
Renaissance45.52K0.00%45.52K$331.88K
Alliancebernstein12.20K-12.20K$88.94K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Farther finance advisors-31.00
Quadrant capital group-110.00
Parallel advisors-176.00
Old point trust & financial services n a-500.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20247421.31%18,643,9415.04%402.62%38111.11%16-20.00%
Mar 31, 202461-7.58%17,749,027-1.42%392.56%18-41.94%2017.65%
Dec 31, 202366-4.35%18,004,54019.63%393.64%316.90%17-10.53%
Sep 30, 2023694.55%15,050,3973.08%322.85%29-30.95%19171.43%
Jun 30, 2023664.76%14,600,62013.01%333.76%4210.53%7-46.15%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv815.89K1.79%-
Fidelity Select Biotechnology629.87K1.48%-478.20K
iShares Russell 2000 ETF540.97K1.19%-1.22K
Invesco Dorsey Wright SmallCap Momt ETF409.00K0.96%-
Vanguard Institutional Extnd Mkt Idx Tr289.25K0.68%-
State St Russell Sm/Mid Cp® Indx NL Cl C213.00K0.47%-
Fidelity Small Cap Index196.51K0.46%-3.61K
Simplify Propel Opportunities ETF200.00K0.44%-
iShares Russell 2000 Growth ETF197.33K0.43%-
DWS Small Cap Core S174.70K0.41%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 27, 2024Hayes Christopher G. CHIEF LEGAL OFFICERSell$23.44K
Aug 26, 2024Hayes Christopher G. CHIEF LEGAL OFFICERSell$69.65K
Aug 26, 2024Goldenberg Gary Chief Medical OfficerSell$26.30K
Aug 27, 2024Goldenberg Gary Chief Medical OfficerSell$8.86K
Aug 26, 2024Bonaccorso Joe CHIEF COMMERCIAL OFFICERSell$65.73K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3-18
2024 Q2--
2024 Q1--
2023 Q4910

VRCA Ownership FAQ


Who Owns Verrica Pharmaceuticals?

Verrica Pharmaceuticals shareholders are primarily institutional investors at 40.11%, followed by 32.18% insiders and 27.71% retail investors. The average institutional ownership in Verrica Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Verrica Pharmaceuticals falls below.

Who owns the most shares of Verrica Pharmaceuticals?

Verrica Pharmaceuticals’s largest shareholders are Perceptive advisors (7.1M shares, 15.27%), Vanguard group (1.27M shares, 2.73%), and Blackrock (1.13M shares, 2.43%). Together, they hold 20.43% of Verrica Pharmaceuticals’s total shares outstanding.

Does Blackrock own Verrica Pharmaceuticals?

Yes, BlackRock owns 2.43% of Verrica Pharmaceuticals, totaling 1.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.23M$. In the last quarter, BlackRock increased its holdings by 15.08K shares, a 1.35% change.

Who is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Propel bio management is Verrica Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.01% of its assets in 424.94K Verrica Pharmaceuticals shares, valued at 3.1M$.

Who is the top mutual fund holder of Verrica Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Verrica Pharmaceuticals shares, with 1.79% of its total shares outstanding invested in 815.89K Verrica Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools